35
Participants
Start Date
July 20, 2021
Primary Completion Date
March 8, 2023
Study Completion Date
February 29, 2024
Pelabresib
Pelabresib monohydrate tablets
Gettysburg Cancer Center, Gettysburg
Madrid - FJD, Madrid
Hospital Universitario Virgen del Rocío, Seville
Gabrail Cancer Center Research, Canton
Start Mountain Region, West Valley City
Hight Technology Hospital Medcenter, Batumi
K. Eristavi National Center of Experimental and Clinical Surgery, Tbilisi
Simon Khechinashvili University Hospital, Tbilisi
START CIOCC Hospital HM Sanchinarro, Madrid
Barcelona HM Nou Delfos, Barcelona
Lead Sponsor
Constellation Pharmaceuticals
INDUSTRY